Clinical Study
Real-Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer
Table 5
Subgroup analysis after DEB-TACE.
| | Alive | Total embolizations | Number; percent | Previous failed chemotherapy | Number; percent | ECOG | Number; percent | Extrahepatic metastases | Number; percent | QoL | Number; percent | SAEs [ = 8] | Percentage |
| | = 6 | 1
2
3 | 4; 66%
1; 16%
1; 16%
Mean = 1.5 | 1
2
3
4
5 | 2; 34%
3; 50%
1; 16%
0
0
Mean = 1.8 | 0
1
2
n/a | 4; 66%
1; 16%
1; 16%
0
Mean = 0.5 | Y
N | 3; 50%
3; 50% | Stable
Delayed
Immediate
n/a | 3; 50%
1; 16%
0
2; 34% | 0 | 0 |
| | OS < 5 months | Total embolizations | Number; percent | Previous failed chemotherapy | Number; percent | ECOG | | Extrahepatic metastases | Number; percent | QoL | Number; percent | SAEs = 8 | SAEs = 8 |
| | = 12 | 1
2
3 | 7; 58%
4; 33%
1; 9%
Mean = 1.3 | 1
2
3
4
5 | 5; 41%
5; 41%
1; 9%
1; 9%
0
Mean = 1.8 | 0
1
2
n/a | 8; 67%
2; 16%
0
2; 16%
Mean = 0.15 | Y
N | 4; 34%
8; 66% | Stable
Delayed
Immediate
n/a | 7; 58%
2; 16%
2; 16%
1; 9% | 7 | 87.5% |
| | OS < 5 months | Total embolizations | Number; percent | Previous failed chemotherapy | Number; percent | ECOG | | Extrahepatic metastases | Number; percent | QoL | Number; percent | SAEs = 8 | SAEs = 8 |
| | = 9 | 1
2
3 | 9; 100%
0
0
Mean = 1.0 | 1
2
3
4
5 | 1; 11%
5; 55%
1; 11%
1; 11%
1; 11%
Mean = 2.5 | 0
1
2
n/a | 2; 22%
6; 66%
1; 11%
0
Mean = 0.9 | Y
N | 4; 44%
5; 56% | Stable
Delayed
Immediate
n/a | 0
2; 22%
6; 67%
1; 11% | 1 | 12.5% |
|
|
